Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Effects of PD-1 Inhibitors on Real-world Treatment Patterns, Outcomes in Advanced HCC
Platinum Chemotherapy, PARP Inhibitors for Gastric or Esophageal Cancers
Identifying HR and NER Deficiencies in Gastric Cancer for Targeted Treatment Strategies